Tag: time

PITTSBURGH, July 3, 2025 /PRNewswire/ -- "I wanted to create a system for commercial kitchens to eliminate grease buildup on hoods and minimize cleaning/maintenance...

World-record-holding mountaineer Tyler Andrews relies on the Wahl® Self-Clip 360™ to stay sharp—mentally and physically—17,600 feet above sea level. STERLING, Ill., July 3, 2025 /PRNewswire/...

Business Activity Index at 54.2%; New Orders Index at 51.3%; Employment Index at 47.2%; Supplier Deliveries Index at 50.3% TEMPE, Ariz., July 3, 2025 /PRNewswire/...

NEW YORK, July 3, 2025 /PRNewswire/ -- Just in time for the summer season, K-beauty brand COSRX is offering exclusive discounts on its newest skincare...

MONTREAL, July 3, 2025 /CNW/ - VIA Rail Canada (VIA Rail) invites the public to listen to its 2025 Annual Public Meeting (APM) to be...

If you’re visiting Budapest in the summer of 2025, we’ve got 7 unique experiences for you that will show you a new side of Hungary.

Bitget Wallet, the leading non-custodial crypto wallet, celebrated their new crypto-linked card, launched in partnership with Mastercard and infra..

Pluvicto® now publicly funded in provinces covering most Canadians, offering renewed hope to those facing progressive PSMA-positive metastatic castration-resistant prostate cancer Momentum builds nationwide as...

MISSISSAUGA, ON, July 3, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is pleased to announce that Michael...

MISSISSAUGA, ON, July 3, 2025 /CNW/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is pleased to announce that Michael...

MONACO, July 03, 2025 (GLOBE NEWSWIRE) -- Forty-two teams, twenty nations, 29 universities and more than one thousand students involved. These are the numbers of the 12th edition of the Monaco Energy Boat Challenge (1-5 July), the event dedicated to the future of yachting organised by Yacht Club de Monaco, with the support of the Prince Albert II of Monaco Foundation, UBS, BMW and SBM Offshore. The goal of the Challenge, which bridges the gap between academic research and the boating industry, is to rethink maritime mobility under real conditions.

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received Institutional Review Board (IRB) approval from Tel Aviv Sourasky Medical Center (TASMC) in Tel Aviv, Israel, for its ongoing Phase 1/2a clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This approval will enable patient enrollment at TASMC, a leading clinical site in Israel, prior to commencing this first-in-human trial at the site.